Tag Archives: sciencedaily

Potential predictive biomarker for response to PD-L1 checkpoint blocker found

The antibody drug, known as MPDL3280A, inhibits the brake protein, PD-L1, reviving the response by immune killer T cells, which target and destroy the cancer cells. In recent clinical trials, the PD-L1 checkpoint blocker caused impressive shrinkage of kidney, melanoma, and lung tumors. But, as with other immunotherapy drugs, many patients saw no benefit. …

Trial shows new imaging system may cut X-ray exposure for liver cancer patients

In a report prepared for presentation Dec. 3 at the 100th annual meeting of the Radiological Society of North America in Chicago (abstract #SSM24-02), the researchers described the results of a clinical trial of the imaging system AlluraClarity, made by Philips Healthcare, on 50 patients with liver cancer. …

TNF inhibitors may increase cancer risk in the eye, researchers report

Mayo researchers studied three patients — two women and a man — who were treated for inflammatory disease and developed melanoma tumors in one eye within a year to two of taking TNF inhibitors. While this type of condition is probably rare, according to the researchers, there might be an increased risk if the patient has a pre-existing nevus (freckle of the eye). …

Symptoms after breast cancer surgery need to be treated on an individual basis — ScienceDaily

The authors state that it is crucial for good aftercare to understand and document a patient’s symptoms and target the treatment accordingly. Special attention will have to be paid to the risk of certain groups of patients: younger, premenopausal women suffer notably more from the effects of breast cancer than older women. In any case, women about to be given treatment for breast cancer should be given detailed information about late sequelae. source : http://www.sciencedaily.com/releases/2014/08/140826085730.htm